Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 1 Results

  1. 1

    WHO statement on depot-medroxyprogesterone acetate (DMPA). Key facts.

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2015. [2] p. (WHO/RHR/15.09)

    The purpose of this Statement is to reiterate and clarify the existing (current) WHO position based on published guidance that is still valid. WHO monitors the evidence in this field closely and will update its guidance as and when new evidence becomes available. The statement includes key facts about depot-medroxyprogesterone acetate (DMPA), a discussion of the safety of DMPA, and current recommendations for its use.
    Add to my documents.